• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Plasticell announces grant of fundamental CombiCult patents in U.S. and Japan

Plasticell announces grant of fundamental CombiCult patents in U.S. and Japan

February 13, 2012
CenterWatch Staff

Patents for CombiCult, combinatorial cell culture platform technology, have been granted in the U.S. and Japan, according to Plasticell, a biotechnology company specializing in high throughput technologies for directed stem cell differentiation.

CombiCult breaks the bottleneck in stem cell R&D programs—the discovery of optimized stem cell differentiation protocols. CombiCult also allows scientists to develop custom cell culture media (e.g. GMP compatible stem cell expansion media for cell therapy), create high value cell lines for toxicity testing in the pharmaceutical, cosmetic and nutrition industries, and to increase yield and decrease cost of bioprocess manufacturing.

“Plasticell's proprietary technology breaks the major bottleneck in current stem cell research,” commented Sir Martin Evans FRS, a founding member of Plasticell’s scientific advisory board and recipient of the Nobel prize for the isolation of embryonic stem cells. “Having followed CombiCult's development for almost a decade, I am delighted that the importance of this revolutionary technology is now being recognized through multiple industry awards and patents.”

Patents covering CombiCult have now been issued in the U.S., Europe, Japan, Australia and Singapore.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing